Renaissance Capital logo

Catalent Priced, NYSE: CTLT

Global provider of oral, injectable and respiratory drug delivery technologies.

Industry: Health Care

First Day Return: -2.5%

Global provider of oral, injectable and respiratory drug delivery technologies.

Catalent (CTLT) Performance

Created with Highcharts 10.3.2Chart context menuCTLT vs. IPO Index (IPOUSA)20152016201720182019202020212022202320242025-100%0%+ 100%+ 200%+ 300%View 5 days5dView 1 month1mView 3 months3mView year to dateYTDView 1 year1yView allAllRenaissance IPO IndexOur ETF tracks the IPO Index